Mirae Asset Global Etfs Holdings Ltd. Collegium Pharmaceutical, Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 17,882 shares of COLL stock, worth $511,961. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,882
Previous 16,270
9.91%
Holding current value
$511,961
Previous $523,000
31.93%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding COLL
# of Institutions
255Shares Held
36.9MCall Options Held
100KPut Options Held
21.1K-
Black Rock Inc. New York, NY5.79MShares$166 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$75.5 Million1.79% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.59MShares$74.1 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$67.2 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$47.4 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $977M
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...